Immunological veterinary medicinal products, including vaccines, are authorised for cattle.
Search results 51 to 64 from a total of 64
| Name | Description | Marketing Authorisation Holder | License Number | License Date | Animal | Further Information |
|---|---|---|---|---|---|---|
|
Rispoval RS+PI3 IntraNasal |
BRSV-Infektion, |
Zoetis Deutschland GmbH |
PEI.V.03416.01.1 | 15.08.2006 | Rind | |
|
Scourguard 3 |
Rotavirus-Infektion, |
Zoetis Deutschland GmbH |
89a/82 | 22.11.2004 | Rind | |
|
Spirovac |
Leptospiren- Infektion |
Zoetis Deutschland GmbH |
PEI.V.03608.01.1 | 29.02.2008 | Rind | |
|
Startvac |
Mastitis (Colibakterien, Staphylokokken) |
Laboratorios Hipra S.A., Spanien |
EU/2/08/092/001-007 | 13.02.2009 | Rind | |
|
SYVAZUL BTV |
Blauzungenkrankheit, Serotypen 1, 4 oder 8 |
Laboratorios Syva, S.A.U., Spanien |
EU/2/18/231/001-012 | 09.01.2019 | Schaf, Rind | |
Tricholor |
Trichophytie |
Ceva Tiergesundheit GmbH |
PEI.V.12134.01.1 | 07.12.2021 | Rind | |
|
Trichovac LTF 130 |
Trichophytie |
Ceva Tiergesundheit GmbH |
95a/97 | 30.03.1999 | Rind | |
|
UBAC |
Mastitis |
Laboratorios Hipra S.A.,Spanien |
EU/2/18/227 | 26.07.2018 | Rind | |
|
Verruvac |
Trichophytie |
Virbac Tierarzneimittel GmbH |
PEI.V.03023.02.1 | 07.04.2015 | Rind | |
|
Versiguard Rabies |
Tollwut |
Zoetis Deutschland GmbH |
PEI.V.03351.01.1 | 03.05.2006 | Hund, Katze, Frettchen, Pferd, Schwein, Ziege, Schaf, Rind | |
|
Zulvac 1+8 Bovis |
Blauzungenkrankheit, Serotypen 1 und 8 |
Zoetis Belgium S.A., Belgien |
EU/2/12/139/001-003 | 08.03.2012 | Rind | |
|
Zulvac BTV |
Blauzungenkrankheit, Serotypen 1, 4 oder 8 |
Zoetis Belgium S.A., Belgien |
EU/2/17/207/001-009 | 25.04.2017 | Rind, Schaf | |
|
Zulvac SBV |
Infektion mit dem Schmallenbergvirus |
Zoetis Belgium S.A., Belgien |
EU/2/14/178/001 | 06.02.2015 | Schaf, Rind | |
|
Zylexis |
Paramunisierung, Stimulierung unspezifischer Immunmechanismen |
Zoetis Deutschland GmbH |
PEI.V.02388.01.1 | 05.11.2001 | Hund, Katze, Pferd, Rind, Schwein |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 519 in BAnz AT 26.07.2024 B6.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 26.07.2024
